Jim DeMesa, MD, BS, MBA
PRESIDENT & CHIEF EXECUTIVE OFFICER, EMERALD HEALTH SCIENCES
San Diego, California, United States
Dr. DeMesa has over 30 years of experience in biotech and pharmaceutical leadership, product development, and clinical and regulatory management. He is a former practicing physician and has completed partnerships and collaborations with pharmaceutical, biotech, and medical device companies. He's raised more than $150 million to advance product development into clinical stage, regulatory approval, and commercialization. Also, former CEO of two public biotech companies: Migenix and GenSci Regeneration Sciences (now part of Integra LifeSciences). He currently serves as Director for two biotech companies: OncoSec Medical and Induce Biologics. Prior to his CEO roles he was Vice President, Medical and Regulatory Affairs at Biodynamics International (now part of RTI Surgical) and Bentley Pharmaceuticals (now part of Teva Pharmaceuticals). Bachelor’s degree in Chemistry, and MD, and MBA degrees from the University of South Florida and medical residency at the University of North Carolina.